R. Gust et al., Structure activity studies on leaving group derivatives of [meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-platinum(II), ARCH PHARM, 332(8), 1999, pp. 261-270
The spatial structures of leaving group derivatives of [meso-1,2-bis(2,6-di
chloro-4-hydroxyphenyl)ethylenediamine]platinum(II) (meso-1-PtL2; L-2 = SO4
, Cl-2, I-2, CBDC (cyclobutane-1,1-dicarboxylate)) were investigated by NMR
methods and correlated with their reactivity against nucleophiles, their e
strogenic potency, and their activity on the hormone dependent MCF-7 mammar
y carcinoma cell line. It was demonstrated that beside the non-leaving grou
p meso-1 the PtL2 moiety of meso-PtL2 complexes is important for the estrog
en receptor binding. Among the tested complexes meso-1-PtI2 possesses the h
ighest affinity for the estrogen receptor for (RBA = 2.6) and represents a
strong estrogen on the MCF-7-2a cell line. The use of CBDC as leaving group
decreases the effects. Meso-1-PtCBDC shows an RBA of 0.06 and has only hal
f of the estrogenic activity. Both complexes are sufficiently stable under
physiological conditions, so a transformation into the dichloroplat inum(II
) complex prior to the binding to the estrogen receptor can be excluded. Du
e to their high stability meso-1-PtI2 and meso-1-PtCBDC were only marginall
y active on the human estrogen receptor positive MCF-7 cell line, while mes
o-1-PtSO4 acid meso-1-PtCl2 reduced the cell growth to T/C-max = 45% and 25
%, respectively.